C$0.035 AIML.CN AI/ML Innovations (CNQ) 14 Jan 2026: Forecast shows downside risk
AIML.CN stock is trading at C$0.035 on the CNQ during market hours on 14 Jan 2026, a flat session with 487,316 shares traded so far. The company, AI/ML Innovations Inc., operates in digital healthcare and wearable AI systems. Volume is above average at 1.33x relative to the 50-day average, but the share price sits well below the 200-day average of C$0.058425. As an AI stocks play in healthcare, liquidity, weak earnings and valuation metrics matter for short-term traders and longer-term investors.
Price snapshot and market context for AIML.CN stock
AI/ML Innovations (AIML.CN) is quoted at C$0.035, with a year high of C$0.185 and year low of C$0.03. Intraday range is narrow: day low C$0.035 and day high C$0.035, reflecting low bid-ask activity. Market cap stands at C$5,889,240.00 and shares outstanding are 168,264,000, which keeps free float and trading depth limited on CNQ in Canada.
Fundamentals and valuation — AIML.CN stock analysis
Trailing EPS is -0.03 and the reported PE is -1.17, which signals persistent losses. Price to sales is 35.00 and price to book is 4.58, both high for a small digital-health firm with minimal revenue per share (0.00079). The company shows a current ratio of 2.09 but negative operating cash flow per share (-0.02635), indicating working capital cover but limited cash generation.
Technical and liquidity signals for AIML.CN stock
Short-term momentum is weak: RSI 40.70 and ADX 14.53 (no clear trend). The 50-day average price is C$0.0394 and the 200-day average is C$0.058425, both above the current price. Average volume is 365,653 vs current volume 487,316, giving a relative volume of 1.33 and suggesting intermittent interest but limited depth.
Meyka AI rates AIML.CN with a score out of 100 and model forecast
Meyka AI rates AIML.CN with a score out of 100: 58.28 | Grade: C+ | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a quarterly price of C$0.02, which compares to the current price C$0.035 and implies an expected downside of -42.86%. These grades and forecasts are model-based projections and not guarantees; we are not financial advisors.
Risks and opportunities tied to AIML.CN stock
Key risks: ongoing negative margins (net margin -39.10%), thin liquidity, and limited revenue per share. Opportunities include patent-pending monitoring tech and any successful wearable pilot that boosts contract revenue. Investors should watch sector news, including broad AI regulation and enterprise deals reported by major outlets like the Wall Street Journal and Reuters for industry tailwinds source source.
Price targets and scenario planning for AIML.CN stock
Scenario targets: a conservative base target C$0.05 (upside 42.86%), a bull-case C$0.12 (upside 242.86%) if commercial traction accelerates, and a bear-case C$0.02 (downside -42.86%) if dilution or contract shortfalls occur. Use the 50/200-day averages and cash-per-share (0.00532) as checkpoints when reassessing targets.
Final Thoughts
AIML.CN stock at C$0.035 on CNQ shows a fragile setup for AI healthcare investors. Fundamentals show negative EPS (-0.03), a negative PE (-1.17), high price-to-sales (35.00) and slender free cash flow, which keep valuation risk high. Liquidity is intermittently above average but overall thin, and technicals (RSI 40.70) show limited upside momentum. Meyka AI’s forecast model projects C$0.02 over the next quarter, implying -42.86% versus the current price; forecasts are model-based projections and not guarantees. For AI stocks strategy we flag AIML.CN as a speculative, high-risk exposure best sized small within a diversified portfolio. Short-term traders should watch volume spikes and contract news; longer-term holders need clear revenue inflection or capital improvements before upgrading conviction. For more data and live tracking, see our Meyka AI-powered market analysis platform and the company site for filings and press updates.
FAQs
What drives AIML.CN stock price movements?
AIML.CN stock reacts to pilot outcomes, contract wins in digital health, liquidity shifts and sector-wide AI news. Given negative earnings and thin trading, small trades or announcements can move price significantly.
Does AIML.CN pay a dividend or show profitability?
No. AIML.CN has no dividend and reports negative EPS (-0.03) with a negative PE (-1.17). Profitability has not yet been achieved and cash generation is limited.
What is Meyka AI’s short-term forecast for AIML.CN stock?
Meyka AI’s forecast model projects a quarterly price of C$0.02, implying -42.86% from C$0.035. Forecasts are model-based projections and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
